FDA Adverse Event Injury Summary report: N

REVERSE SHOULDER SYSTEM HUMERAL REVERSE METAPHYSIS +9MM/0

MDR report key: 12655740 · Received October 19, 2021

Report

Report Number
3005180920-2021-00812
Event Type
Injury
Date Received
October 19, 2021
Date of Event
September 16, 2021
Report Date
October 19, 2021
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
PHX
UDI-DI
07630040706186
PMA / PMN Number
K170452
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 1

BATCH REVIEW PERFORMED ON 23 SEPTEMBER 2021: LOT 2001145: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 26-AGO-2020. EXPIRATION DATE: 2025-AGO-18. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT. ADDITIONAL DEVICES INVOLVED: BATCH REVIEWS PERFORMED ON 23 SEPTEMBER 2021: REVERSE SHOULDER SYSTEM 04.01.0122 HUMERAL REVERSE HC LINER Ø39/+0MM (K170452) LOT 2100435: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 25-MAR-2021. EXPIRATION DATE: 2026-MAR-15. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT. REVERSE SHOULDER SYSTEM 04.01.0173 GLENOSPHERE 39XØ27 (K170452) LOT 2004000: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 24-MAR-2021. EXPIRATION DATE: 2026-MAR-10. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT.

Description of Event or Problem · 1

THE PATIENT CAME IN REPORTING LATERAL INSTABILITY AND THE CAUSE OF THE INSTABILITY IS LAXITY. ABOUT 1 MONTH AND A HALF AFTER THE PRIMARY SURGERY, THE SURGEON REVISED THE GLENOSPHERE, LINER, AND METAPHYSIS. THE SURGERY WAS COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1555050 REVERSE SHOULDER SYSTEM HUMERAL REVERSE METAPHYSIS +9MM/0 SHOULDER HUMERAL METAPHYSIS PHX MEDACTA INTERNATIONAL SA 04.01.0111 2001145 07630040706186

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention